Recent developments in the stem cell biology provided new hopes in treatment of diseases
and disorders that yet cannot be treated. Stem cells have the potential to differentiate into …

The past 20 years have seen a gain in knowledge on microglia biology and microglia
functions in disease that exceeds the expectations formulated when the microglia “immune …

Backgrounds Alzheimer's disease is the most common cause of dementia, and currently,
there is no disease-modifying treatment. Favorable functional outcomes and reduction of …

Alzheimer's disease (AD) is characterized by the accumulation of β-amyloid peptide (Aβ) in
the brain because of an imbalance between Aβ production and clearance. Neprilysin (NEP) …

Alzheimer's disease (AD) is a disabling and highly prevalent neurodegenerative condition,
for which there are no effective therapies. Soluble oligomers of the amyloid-β peptide (AβOs) …

In an ever-increasing aged world, Alzheimer's disease (AD) represents the first cause of
dementia and one of the first chronic diseases in elderly people. With 55 million people …

Mesenchymal stem cells (MSCs) can differentiate into not only cells of mesodermal
lineages, but also into endodermal and ectodermal derived elements, including neurons …

Human umbilical cord blood-derived mesenchymal stem cells (hUCB-MSC) have a potential
therapeutic role in the treatment of neurological disorders, but their current clinical usage …

Alzheimer's disease (AD) is characterized by the deposition of amyloid-β peptide (Aβ) and
the formation of neurofibrillary tangles. Transplantation of bone marrow-derived …

Abstract Background Mesenchymal stem cells (MSCs) have been explored as promising
tools for treatment of several neurological and neurodegenerative diseases. MSCs release …